171 related articles for article (PubMed ID: 2254762)
1. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS; Rarick MU; Bernstein-Singer M; Espina BM; Jones B; Montgomery T; Sharma D; Rasheed S; Levine AM
J Biol Response Mod; 1990 Oct; 9(5):512-6. PubMed ID: 2254762
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
[TBL] [Abstract][Full Text] [Related]
8. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM
AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
[TBL] [Abstract][Full Text] [Related]
9. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Evans LM; Itri LM; Campion M; Wyler-Plaut R; Krown SE; Groopman JE; Goldsweig H; Volberding PA; West SB; Mitsuyasu RT
J Immunother (1991); 1991 Feb; 10(1):39-50. PubMed ID: 1826454
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
Mitrou PS; Fischer C; Huhn D; Rasokat H; Ring J; Bergmann L
Onkologie; 1988 Feb; 11(1):61-2. PubMed ID: 2452394
[TBL] [Abstract][Full Text] [Related]
16. Chemo-immunotherapy of advanced AIDS-related Kaposi's sarcoma.
Aversa SM; Cattelan AM; Salvagno L; Meneghetti F; Francavilla E; Sattin L; Sasset L; Cadrobbi P
Tumori; 1999; 85(1):54-9. PubMed ID: 10228499
[TBL] [Abstract][Full Text] [Related]
17. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM
J Biol Response Mod; 1988 Aug; 7(4):359-64. PubMed ID: 3049944
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
19. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification.
Laine L; Amerian J; Rarick M; Harb M; Gill PS
Am J Gastroenterol; 1990 Aug; 85(8):959-61. PubMed ID: 1695812
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
